VISTAGEN THERAPEUTICS, INC. (VTGN) Revenue 2017–2026
VISTAGEN THERAPEUTICS, INC. (VTGN) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.3MFY2026 · since FY2017: $1.3M → $1.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $1.3M | +161.1% |
| FY2025 | $486,000 | -54.3% |
| FY2024 | $1.1M | +568.7% |
| FY2023 | -$227,000 | -120.5% |
| FY2022 | $1.1M | +1.8% |
| FY2021 | $1.1M | — |
| FY2020 | $0 | — |
| FY2018 | $0 | -100.0% |
| FY2017 | $1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VTGN financial trends
VTGN Net incomeVTGN Net marginVTGN Gross profitVTGN Gross marginVTGN Operating incomeVTGN Operating marginVTGN Operating cash flowVTGN Free cash flowVTGN Capital expendituresVTGN Return on equityVTGN Stock buybacksVTGN Dividends paidVTGN Total assetsVTGN Total liabilitiesVTGN Shareholders’ equityVTGN overview →